ZA963545B - New process for the preparation of ropivacaine hydrochloride monohydrate - Google Patents

New process for the preparation of ropivacaine hydrochloride monohydrate

Info

Publication number
ZA963545B
ZA963545B ZA963545A ZA963545A ZA963545B ZA 963545 B ZA963545 B ZA 963545B ZA 963545 A ZA963545 A ZA 963545A ZA 963545 A ZA963545 A ZA 963545A ZA 963545 B ZA963545 B ZA 963545B
Authority
ZA
South Africa
Prior art keywords
preparation
new process
hydrochloride monohydrate
ropivacaine hydrochloride
ropivacaine
Prior art date
Application number
ZA963545A
Other languages
English (en)
Inventor
Peter Jaksch
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ZA963545B publication Critical patent/ZA963545B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA963545A 1995-05-16 1996-05-03 New process for the preparation of ropivacaine hydrochloride monohydrate ZA963545B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9501808A SE9501808D0 (sv) 1995-05-16 1995-05-16 New process

Publications (1)

Publication Number Publication Date
ZA963545B true ZA963545B (en) 1996-11-18

Family

ID=20398325

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA963545A ZA963545B (en) 1995-05-16 1996-05-03 New process for the preparation of ropivacaine hydrochloride monohydrate

Country Status (34)

Country Link
US (1) US5959112A (zh)
EP (1) EP0828711B1 (zh)
JP (1) JP3079112B2 (zh)
KR (1) KR100425232B1 (zh)
CN (1) CN1121388C (zh)
AR (1) AR002737A1 (zh)
AT (1) ATE207900T1 (zh)
AU (1) AU696875B2 (zh)
BR (1) BR9608820A (zh)
CA (1) CA2219308C (zh)
CZ (1) CZ290576B6 (zh)
DE (1) DE69616543T2 (zh)
DK (1) DK0828711T3 (zh)
EE (1) EE03394B1 (zh)
ES (1) ES2166888T3 (zh)
HK (1) HK1009805A1 (zh)
HU (1) HU221793B1 (zh)
IL (1) IL118178A (zh)
IN (1) IN185146B (zh)
IS (1) IS1832B (zh)
MY (1) MY115018A (zh)
NO (1) NO309035B1 (zh)
NZ (1) NZ308249A (zh)
PL (1) PL184767B1 (zh)
PT (1) PT828711E (zh)
RU (1) RU2167153C2 (zh)
SA (1) SA96160764B1 (zh)
SE (1) SE9501808D0 (zh)
SK (1) SK281812B6 (zh)
TR (1) TR199701362T1 (zh)
TW (1) TW340841B (zh)
UA (1) UA46770C2 (zh)
WO (1) WO1996036606A1 (zh)
ZA (1) ZA963545B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2222614T3 (es) 1997-11-12 2005-02-01 Mitsubishi Chemical Corporation Derivados de purina y medicina que los contiene como ingrediente activo.
DE60006663T2 (de) 1999-05-11 2004-10-07 Mitsubishi Chem Corp Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung
AU1037701A (en) * 1999-10-20 2001-04-30 Smithkline Beecham Plc Process for the preparation of 4-(fluorophenyl)piperidine esters
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009044404A1 (en) * 2007-10-01 2009-04-09 Ramniwas Goel Process for the preparation of (s)-ropivacaine hydrochloride monohydrate
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
WO2014009964A1 (en) * 2012-07-11 2014-01-16 Neon Laboratories Limited Process for enantiomeric enrichment of 2 ', 6 ' - pipecoloxylidide
CN103086954A (zh) * 2013-02-04 2013-05-08 山东省医药工业研究所 一种制备罗哌卡因的方法
CN104003930B (zh) * 2014-06-13 2016-06-08 山东金诃药物研究开发有限公司 一种盐酸罗哌卡因的制备方法
CN113105386B (zh) * 2021-04-10 2022-11-25 河北一品制药股份有限公司 一种盐酸罗哌卡因一水合物工业化的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE341404B (zh) * 1967-05-18 1971-12-27 Sterling Drug Inc
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Also Published As

Publication number Publication date
SK151297A3 (en) 1998-05-06
ES2166888T3 (es) 2002-05-01
IL118178A0 (en) 1996-09-12
CN1189822A (zh) 1998-08-05
AU5783296A (en) 1996-11-29
IN185146B (zh) 2000-11-25
DE69616543T2 (de) 2002-06-27
EP0828711B1 (en) 2001-10-31
NZ308249A (en) 1998-08-26
AR002737A1 (es) 1998-04-29
JP3079112B2 (ja) 2000-08-21
IS4607A (is) 1997-11-04
KR19990014827A (ko) 1999-02-25
HUP9900327A2 (hu) 1999-05-28
PT828711E (pt) 2002-04-29
NO309035B1 (no) 2000-12-04
CZ345297A3 (cs) 1998-03-18
NO975220L (no) 1997-11-13
KR100425232B1 (ko) 2004-05-20
CA2219308A1 (en) 1996-11-21
PL184767B1 (pl) 2002-12-31
PL323461A1 (en) 1998-03-30
MY115018A (en) 2003-03-31
DK0828711T3 (da) 2002-02-11
US5959112A (en) 1999-09-28
AU696875B2 (en) 1998-09-17
IS1832B (is) 2002-10-30
SA96160764B1 (ar) 2006-07-30
HU221793B1 (hu) 2003-01-28
IL118178A (en) 2003-07-31
CA2219308C (en) 2007-12-18
RU2167153C2 (ru) 2001-05-20
EE9700301A (et) 1998-06-15
ATE207900T1 (de) 2001-11-15
EP0828711A1 (en) 1998-03-18
EE03394B1 (et) 2001-04-16
BR9608820A (pt) 1999-06-15
TR199701362T1 (xx) 1998-05-21
HK1009805A1 (en) 1999-06-11
TW340841B (en) 1998-09-21
JPH11505242A (ja) 1999-05-18
SE9501808D0 (sv) 1995-05-16
SK281812B6 (sk) 2001-08-06
NO975220D0 (no) 1997-11-13
CZ290576B6 (cs) 2002-08-14
WO1996036606A1 (en) 1996-11-21
DE69616543D1 (de) 2001-12-06
UA46770C2 (uk) 2002-06-17
CN1121388C (zh) 2003-09-17
HUP9900327A3 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
GB2297255B (en) Process for preparing phencynonate hydrochloride of alpha configuration
IL117188A0 (en) Process for the preparation of thietanones
HUP9600255A1 (en) Various forms of paroxetin hydrochloride and process for their preparation
HUP9602957A2 (en) Process for the preparation of dihalo- and dihidroxi-azolopyrimidines
HUP9801913A3 (en) Process for the preparation of lercanidipine hydrochloride
ZA963545B (en) New process for the preparation of ropivacaine hydrochloride monohydrate
HUP9904034A3 (en) New process for the preparation of phenylimidazolidine derivatives
HUP9600321A1 (en) Process for preparation of n-substituted cyclic-imide-derivatives
HUP9903481A3 (en) Process for the preparation of 1-aryl-1-cyanocyclobutane derivatives
IL142218A0 (en) PROCESS FOR THE PREPARATION OF (-) -α- DIFLUORMETHYLORNITHINE MONOHYDROCHLORIDE MONOHYDRATE
IL115090A0 (en) Process for the preparation of p-bromofluorobenzene
HUP0004503A3 (en) Process for the preparation of paroxetine hydrochloride
SI0828711T1 (en) New process for the preparation of ropivacaine hydrochloride monohydrate
IL117228A (en) Process for preparing loracarbef monohydrate
HRP960445B1 (en) New process for the preparation of ropivacaine hydrochloride monohydrate
EP0752419A3 (de) Verfahren zur Herstellung von N-substituierten 4-Ketoprolin-Derivaten
AU1396400A (en) Process for the preparation of paroxetine hydrochloride
AU6481799A (en) Process for the preparation of paroxetine hydrochloride
HUP9901543A3 (en) Process for the preparation of hydroxysulfone derivatives
IL118732A (en) Process for the preparation of arylidene-substituted alkylcycloalkanones
HUP9600316A2 (en) Process for the preparation of n-(ortho-alkyl-phenyl)-imides
ZA961345B (en) Process for the preparation of theitane amines
EP0750002A3 (de) Verfahren zur Herstellung von Poly-o-hydroxyamiden
AU3920597A (en) Process for the production of dexfenfluramine hydrochloride
SI0824517T1 (en) A process for the preparation of lercanidipine hydrochloride